CW Curtiss-Wright Corporation

Research status: Primary-source verified through Q2 2026. Valuation basis: approximately $648 in late August 2026; refresh before any capital decision.

Curtiss-Wright is a high-quality mission-critical industrial platform with unusually attractive overlap between Defence and Energy. Its businesses span naval nuclear propulsion components, defense electronics, aerospace systems, commercial nuclear equipment and industrial technologies. Q2 2026 sales were $924M, +5% YoY; adjusted operating margin reached 19.4%, +110 bps; adjusted EPS was $3.72, +15%; new orders were $1.1B, producing 1.16x book-to-bill; backlog reached $4.5B, +10% versus year-end 2025; and free cash flow was $160M, or 116% conversion. Management raised FY2026 guidance to 8–9% sales growth, 19.1–19.3% adjusted operating margin, $15.10–15.40 adjusted EPS and $585–605M FCF.

The business quality is strong; the main gating issue is valuation. At roughly 42x current-year adjusted EPS, the stock already discounts a long runway of naval, defense electronics and nuclear growth. PowerFund should treat CW as a premium compounder to buy on dislocation, not a theme box to fill at any price.

PowerFund 24-month scenarios: Bear 25% = $504; Base 50% = $782; Bull 25% = $1,120; weighted $797, ~10.9% annualized. 60-month: Bear $528; Base $1,080; Bull $1,800; weighted $1,122, ~11.6% annualized. These are PowerFund scenarios, not company guidance or analyst targets.

Investment case

Curtiss-Wright owns highly engineered, qualification-intensive products embedded in programs where reliability, certification and long asset lives create strong switching costs. The Naval & Power segment benefits from U.S. naval nuclear propulsion and commercial nuclear demand; Defense Electronics participates in embedded computing, communications and mission systems; Aerospace & Industrial adds diversification.

The thesis is attractive because the company can compound through a mix of program longevity, rising defense budgets, nuclear investment, margin expansion and disciplined capital allocation. Unlike many defense primes, CW often supplies critical subsystems/components rather than bearing full platform-development risk.

The thesis is investable if (1) orders/book-to-bill remain healthy across Naval & Power and Defense Electronics, (2) margins continue compounding toward/above current levels without starving R&D/capacity, (3) FCF conversion stays strong, and (4) nuclear growth converts into durable backlog rather than speculative announcements.

Verified operating baseline

• Q2 2026 sales: $924M, +5% YoY.
• Adjusted operating margin: 19.4%, +110 bps.
• Adjusted EPS: $3.72, +15%.
• New orders: $1.1B, +8%; book-to-bill 1.16x.
• Backlog: $4.5B, +10% vs. 31 Dec 2025.
• Q2 FCF: $160M, 116% conversion.
• FY2026 guidance: sales $3.768–3.813B; adjusted margin 19.1–19.3%; adjusted EPS $15.10–15.40; FCF $585–605M.
• FY2025 segment sales: Aerospace & Industrial ~$977M; Defense Electronics ~$1.019B; Naval & Power ~$1.503B.

Valuation scenarios

24 months

Weighted value: ~$797.

60 months

Bear $528 / Base $1,080 / Bull $1,800; weighted ~$1,122.

• Continued record/near-record Defense Electronics orders and backlog.
• U.S. naval nuclear shipbuilding/submarine investment and capacity expansion.
• Commercial nuclear/advanced-reactor wins, including systems for emerging reactor platforms.
• Sustained 100%+ FCF conversion and buybacks funded from internally generated cash.
• Margin expansion through mix, productivity and higher-value electronics.
• Bolt-on M&A in niche mission-critical technologies without balance-sheet strain.
• Further upward revisions to FY2026/FY2027 EPS/FCF.

• Valuation: current multiple leaves limited room for ordinary execution disappointment.
• Program timing: naval/defense procurement can shift between periods because of budgets, appropriations or platform schedules.
• Government concentration: substantial exposure to U.S. defense priorities and procurement rules.
• Nuclear execution: advanced reactor opportunities may take years to become material.
• Supply-chain/capacity: specialized components and labor can constrain delivery.
• Margin expectations: current high margins may attract competition or prove harder to expand further.
• Acquisition risk: disciplined M&A is part of the model; overpaying could dilute returns.
• Portfolio factor: CW improves Defence exposure but still has some long-duration valuation sensitivity at its premium multiple.

WARNING / FREEZE ADDITIONS

• Book-to-bill falls below 1.0 for two quarters while backlog also declines.
• Defense Electronics orders weaken materially without a program-timing explanation.
• Adjusted operating margin falls below ~18% for two quarters.
• FCF conversion falls below ~80% on a trailing-year basis without timing explanation.
• The stock remains >40x forward EPS while earnings revisions flatten.

REDUCE

• Backlog declines >10% YoY across multiple end markets.
• FY EPS expectations fall >10% because of execution rather than timing.
• Naval & Power or Defense Electronics loses a major program/design position.
• Large acquisition pushes leverage materially higher without compelling ROIC.

EXIT / THESIS INVALIDATED

• Mission-critical qualification/switching advantages erode and pricing/margins structurally weaken.
• Naval nuclear or defense-electronics share losses become persistent across several programs.
• FCF conversion structurally deteriorates despite reported EPS growth.
• Capital allocation shifts toward expensive transformational M&A that breaks the niche-compounder model.

CW competes with a mix of large aerospace/defense companies and specialized subsystem suppliers. Its moat is strongest where qualification cycles are long, failure costs are high and installed programs run for decades. In naval nuclear and certain defense-electronics niches, the relevant competition is less about lowest unit price and more about certified performance and program incumbency.

Commercial nuclear provides optionality but should not be valued like software: project timing is long and regulatory. The highest-confidence earnings stream remains existing defense/naval programs.

Portfolio interaction: CW is one of the best theme-diversifying candidates because it strengthens Defence while adding nuclear-related Energy exposure. However, at the current valuation its expected return is below ISRG/VST/FN-type opportunities. It belongs on the watchlist now and in the portfolio after a better entry or meaningful earnings revisions.

1. Break the $4.5B backlog by segment and estimate funded vs. longer-dated program content.
2. Track Defense Electronics book-to-bill and major program wins quarterly.
3. Map U.S. submarine/carrier production plans to CW revenue capacity and the $80M Cheswick expansion.
4. Separate commercial nuclear revenue from advanced-reactor optionality; do not capitalize speculative awards prematurely.
5. Track FCF conversion, buybacks and M&A ROIC.
6. Compare CW valuation/growth with HEI, TDG, HWM and selected defense-electronics suppliers.
7. Establish preferred entry bands after Q3 results; current valuation requires either a correction or faster EPS revisions.

Next review: Q3 2026 results or major naval/nuclear award.